Rational design of copper( i )-doped metal–organic frameworks as dual-functional nanocarriers for combined chemo–chemodynamic therapy
Source abstract
Abstract
Combination therapies are an increasingly important part of the antitumor medicine armamentarium. However, developing desirable nanomaterials for combination therapies is still a great challenge. Herein, a biocompatible Cu(I)-doped metal-organic framework (MOF) (denoted as CuZn-ZIF) is designed as a novel dual-functional nanocarrier. Doxorubicin molecules are covalently bound to the surface of the CuZn-ZIF and released by the cleavage of chemical bonds in an acidic environment, demonstrating the capacity of controlled drug release. More importantly, CuZn-ZIF nanocarriers can simultaneously play the role of nanocatalysts, capable of catalyzing H2O2 into a highly reactive intracellular toxic hydroxyl radical (˙OH). An in vivo study reveals that nanoparticles exhibit high antitumor efficacy through the combined performance of DOX and Cu(I), proving the great potential of this copper(I)-based MOF for combined chemo-chemotherapy to improve therapeutic efficacy.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Silicon and Advanced Semiconductor Materials, ZJU-Hangzhou Global Scientific and Technological Innovation Center, School of Materials Science and Engineering, Zhejiang University, Hangzhou 310027, China
Department of Anaesthesiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China
Funding
National Natural Science Foundation of China · Science and Technology Department of Zhejiang Province
References (49)
Show source-provided references
1. Souho · Biotechnol. Adv. · 2018 · 36 · 192810.1016/j.biotechadv.2018.08.001 ↗
2. Zhang · ACS Appl. Mater. Interfaces · 2017 · 9 · 2733210.1021/acsami.7b08451 ↗
3. Chen · Sci. Technol. Adv. Mater. · 2019 · 20 · 104310.1080/14686996.2019.1682467 ↗
4. Allen · Adv. Drug Delivery Rev. · 2017 · 9 · 27332
5. Sun · Small · 2019 · 15 · 190115610.1002/smll.201901156 ↗
6. Li · Adv. Funct. Mater. · 2021 · 31 · 210024310.1002/adfm.202100243 ↗
7. Deng · Adv. Sci. · 2021 · 8 · 200250410.1002/advs.202002504 ↗
8. Li · J. Controlled Release · 2022 · 347 · 18310.1016/j.jconrel.2022.05.003 ↗
9. Yang · Theranostics · 2023 · 13 · 29510.7150/thno.80687 ↗
10. Gao · J. Mater. Chem. B · 2019 · 7 · 359910.1039/C9TB00525K ↗
11. Wang · Nano Today · 2020 · 35 · 10094610.1016/j.nantod.2020.100946 ↗
12. Xiang · Biomaterials · 2021 · 277 · 12107110.1016/j.biomaterials.2021.121071 ↗
13. Ma · Adv. Mater. · 2022 · 34 · 210756010.1002/adma.202107560 ↗
14. Zhang · Coord. Chem. Rev. · 2019 · 399 · 21302210.1016/j.ccr.2019.213022 ↗
15. Yang · Small · 2020 · 16 · 190684610.1002/smll.201906846 ↗
16. Zhao · Front. Chem. · 2021 · 9 · 83417110.3389/fchem.2021.834171 ↗
17. Hu · Coord. Chem. Rev. · 2022 · 180 · 107595
18. Zhang · Microchem. J. · 2019 · 399 · 213022
19. Horcajada · Chem. Rev. · 2012 · 112 · 123210.1021/cr200256v ↗
20. Bazargan · Coord. Chem. Rev. · 2021 · 445 · 21410710.1016/j.ccr.2021.214107 ↗
21. Nazari · J. Mater. Chem. B · 2022 · 10 · 882410.1039/D2TB01787C ↗
22. Rahmati · Inorg. Chem. Front. · 2021 · 8 · 358110.1039/D1QI00300C ↗
23. Bazargan · Dalton Trans. · 2019 · 48 · 547610.1039/C9DT00542K ↗
24. Mirzaei · CrystEngComm · 2014 · 16 · 535210.1039/c4ce00325j ↗
25. Cheng · Adv. Funct. Mater. · 2017 · 27 · 170413510.1002/adfm.201704135 ↗
26. Chen · Nano Lett. · 2020 · 20 · 814110.1021/acs.nanolett.0c03127 ↗
27. Xu · J. Nanobiotechnol. · 2021 · 19 · 110.1186/s12951-020-00755-7 ↗
28. Wen · Small · 2021 · 17 · 200506410.1002/smll.202005064 ↗
29. Zheng · J. Am. Chem. Soc. · 2016 · 138 · 96210.1021/jacs.5b11720 ↗
30. He · J. Am. Chem. Soc. · 2014 · 136 · 518110.1021/ja4098862 ↗
31. Yang · J. Am. Chem. Soc. · 2019 · 141 · 378210.1021/jacs.8b11996 ↗
32. Wang · ACS Appl. Mater. Interfaces · 2023 · 15 · 1859810.1021/acsami.2c21192 ↗
33. Li · Chem. Eng. J. · 2022 · 437 · 13536910.1016/j.cej.2022.135369 ↗
34. Lu · Adv. Healthcare Mater. · 2021 · 10 · 210097810.1002/adhm.202100978 ↗
35. Jiang · Biomaterials · 2019 · 197 · 4110.1016/j.biomaterials.2019.01.001 ↗
36. Shen · Adv. Funct. Mater. · 2021 · 31 · 210610610.1002/adfm.202106106 ↗
37. Zhao · Adv. Mater. · 2022 · 34 · 220458510.1002/adma.202204585 ↗
38. Wang · ACS Appl. Mater. Interfaces · 2023 · 15 · 842410.1021/acsami.2c22682 ↗
39. Li · ACS Appl. Mater. Interfaces · 2023 · 15 · 1648210.1021/acsami.3c00562 ↗
40. Wang · Angew. Chem., Int. Ed. · 2018 · 57 · 783610.1002/anie.201803766 ↗
41. Zhang · J. Mater. Chem. A · 2018 · 6 · 426010.1039/C7TA09969J ↗
42. Nordin · RSC Adv. · 2014 · 4 · 3329210.1039/C4RA03593C ↗
43. Kumar · J. Mol. Struct. · 2023 · 1284 · 13536510.1016/j.molstruc.2023.135365 ↗
44. Yang · Ceram. Int. · 2022 · 48 · 3414810.1016/j.ceramint.2022.08.249 ↗
45. Guo · Angew. Chem., Int. Ed. · 2021 · 60 · 27410.1002/anie.202010828 ↗
46. Sengupta · J. Am. Chem. Soc. · 2023 · 145 · 2049210.1021/jacs.3c06393 ↗
47. Yen · Chem. – Eur. J. · 2016 · 22 · 292510.1002/chem.201505005 ↗
48. Imosemi · J. Biochem. Mol. Toxicol. · 2022 · 36 · 110.1002/jbt.22962 ↗
49. Fiallo · J. Pharm. Sci. · 1998 · 87 · 96710.1021/js970436l ↗